Cited by 183Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.

The forgotten APOE allele: A review of the evidence and suggested mechanisms for the protective effect of APOE ɛ2

Suri, Sana, Heise, Verena, Trachtenberg, Aaron J., Mackay, Clare E.·2013·Neuroscience & Biobehavioral Reviews

DOI 10.1016/j.neubiorev.2013.10.010

Open this paper in CoChat — free account

Abstract

Ongoing efforts to improve survival, and enhance quality of life have led biomedical research to focus on disease and the mechanisms that increase risk for disease. The other side of that coin may be as important, i.e. examining the protective factors that allow some individuals to enjoy long, healthy lives. One of the best examples of a gene that positively influences cognitive health is the apolipoprotein (APOE) ɛ2 allele. The APOE ɛ4 allele is a well-established risk factor for Alzheimer's disease (AD) and has thus dominated the APOE literature, with the putative protective role of ɛ2 receiving little attention. This review describes the effects of APOE ɛ2 on the structure and function of the brain. With a focus on neurodegeneration, we discuss evidence for APOE ɛ2's protective effects, explore some key mechanisms through which this protection may be conferred, and address a few inconsistencies in the literature. Understanding the mechanisms that underlie the association between APOE ɛ2, cognition and longevity may provide new targets for research on promoting life-long health.

Integrity signals

Registry

Crossref · 10.1016/j.neubiorev.2013.10.010

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“The hippocampus and entorhinal cortex, lying within the medial temporal lobe, are among the first brain regions to develop the hallmark AD-related neuropathological lesions, perhaps as early as 20 years before the onset of clinical symptoms (Braak and Braak, 1991).”
Background
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
A synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
The basis of anisotropic water diffusion in the nervous system—A technical review.
Beaulieu, C. (2002) · NMR in Biomedicine · doi:10.1002/nbm.782 · Cited by 4,628
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
The moulding of senescence by natural selection
Hamilton, W. D. O. (1966) · Journal of Theoretical Biology · doi:10.1016/0022-5193(66)90184-6 · Cited by 2,289
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920
Distinct patterns of brain activity in young carriers of the APOE -ε4 allele
Filippini, N., MacIntosh, B. J., Hough, M. G., Goodwin, G. M., Frisoni, G. B., Smith, S. M., Matthews, P. M., Beckmann, C. F., & Mackay, C. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811879106 · Cited by 1,613
Self-citation

Show all 126 references

Sorted by citations

The Amyloid-β Pathway in Alzheimer’s Disease
Hampel, H., Hardy, J., Blennow, K., Chen, C., Perry, G., Kim, S. H., Villemagne, V. L., Aisen, P., Vendruscolo, M., Iwatsubo, T., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01249-0 · Cited by 1,952
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis
Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R. J., Visser, P. J., Aalten, P., Aarsland, D., Alcolea, D., et al. (2015) · JAMA · doi:10.1001/jama.2015.4668 · Cited by 1,610
Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases
Chin-Chan, M., Navarro-Yepes, J., & Quintanilla‐Vega, B. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00124 · Cited by 746
Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis
Neu, S. C., Pa, J., Kukull, W., Beekly, D., Kuzma, A., Gangadharan, P., Wang, L.-S., Romero, K., Arneric, S. P., Redolfi, A., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.2188 · Cited by 674
ApoE4: an emerging therapeutic target for Alzheimer’s disease
Safieh, M., Korczyn, A. D., & Michaelson, D. M. (2019) · BMC Medicine · doi:10.1186/s12916-019-1299-4 · Cited by 449
APOE genotype and cognition in healthy individuals at risk of Alzheimer's disease: A review
O'Donoghue, M. C., Murphy, S. E., Zamboni, G., Nobre, A. C., & Mackay, C. E. (2018) · Cortex · doi:10.1016/j.cortex.2018.03.025 · Cited by 191
Self-citation
Evaluation of Amyloid Protective Factors and Alzheimer Disease Neurodegeneration Protective Factors in Elderly Individuals
Vemuri, P., Knopman, D. S., Lesnick, T. G., Przybelski, S. A., Mielke, M. M., Graff‐Radford, J., Murray, M. E., Roberts, R. O., Vassilaki, M. E., Lowe, V. J., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0244 · Cited by 144
Reduced cerebrovascular reactivity in young adults carrying the APOE ε4 allele
Suri, S., Mackay, C. E., Kelly, M. E., Germuska, M. A., Tunbridge, E. M., Frisoni, G. B., Matthews, P. M., Ebmeier, K. P., Bulte, D. P., & Filippini, N. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.1755 · Cited by 122
Self-citation
APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer’s disease
Vélez, J. I., Lopera, F., Sepulveda-Falla, D., Patel, H. R., Johar, A. S., Chuah, A., Tobón, C., Rivera, D., Villegas, A., Cai, Y., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.177 · Cited by 111
Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models
Zhao, L., Gottesdiener, A. J., Parmar, M., Li, M., Kaminsky, S. M., Chiuchiolo, M. J., Sondhi, D., Sullivan, P. M., Holtzman, D. M., Crystal, R. G., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.020 · Cited by 107
APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations
Shinohara, M., Kanekiyo, T., Yang, L., Linthicum, D., Shinohara, M., Fu, Y., Price, L., Frisch‐Daiello, J. L., Han, X., Fryer, J. D., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24628 · Cited by 111
Accelerating stem cell trials for Alzheimer's disease
Hunsberger, J. G., Rao, M. S., Kurtzberg, J., Bulte, J. W. M., Atala, A., LaFerla, F. M., Greely, H. T., Sawa, A., Gandy, S., Schneider, L. S. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00332-4 · Cited by 98
Genetics of human longevity within an eco-evolutionary nature-nurture framework
Giuliani, C., Garagnani, P., & Franceschi, C. (2018) · Circulation Research · doi:10.1161/circresaha.118.312562 · Cited by 92
Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques
Monsell, S. E., Kukull, W. A., Roher, A. E., Maarouf, C. L., Serrano, G., Beach, T. G., Caselli, R. J., Montine, T. J., & Reiman, E. M. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1721 · Cited by 82
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
Mattsson, N., Groot, C., Jansen, W. J., Landau, S. M., Villemagne, V. L., Engelborghs, S., Mintun, M. M., Lleo, A., Molinuevo, J. L., Jagust, W. J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.009 · Cited by 88
Gray matter maturation and cognition in children with different APOE ε genotypes
Chang, L., Douet, V., Bloss, C. S., Lee, K., Pritchett, A., Jernigan, T. L., Akshoomoff, N. A., Murray, S. S., Frazier, J. A., Kennedy, D. N., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002939 · Cited by 81
Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights
Das, M., & Gursky, O. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17344-3_8 · Cited by 80
The Complex Role of Apolipoprotein E in Alzheimer’s Disease: an Overview and Update
Mahoney‐Sanchez, L., Belaidi, A. A., Bush, A. I., & Ayton, S. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0839-z · Cited by 84
ApoE-2 Brain-Targeted Gene Therapy Through Transferrin and Penetratin Tagged Liposomal Nanoparticles
Rodrigues, B. D. S., Kanekiyo, T., & Singh, J. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2691-7 · Cited by 82
The Contribution of Genetic Factors to Cognitive Impairment and Dementia: Apolipoprotein E Gene, Gene Interactions, and Polygenic Risk
Fan, J., Tao, W., Li, X., Li, H., Zhang, J., Wei, D., Chen, Y., & Zhang, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051177 · Cited by 87
Age Modifies the Association Between Apolipoprotein E Genotype and Alzheimer's Disease: A CSF Biomarker-Based Multicentric Case-Control Study
Sadikki, H., Fayossé, A., Cognat, E., Sabia, S., Engelborghs, S., Wallon, D., Alexopoulos, P., Blennow, K., Zetterberg, H., Parnetti, L., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1003289 · Cited by 87
Lipids in Amyloid-β Processing, Aggregation, and Toxicity
Morgado, I., & Garvey, M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17344-3_3 · Cited by 72
Opposite Neural Trajectories of Apolipoprotein E ϵ4 and ϵ2 Alleles with Aging Associated with Different Risks of Alzheimer's Disease
Shu, H., Shi, Y., Chen, G., Wang, Z., Liu, D., Yue, C., Ward, B. D., Li, W., Xu, Z., Chen, G., et al. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu237 · Cited by 63
Sex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals
Yan, S., Zheng, C., Paranjpe, M. D., Li, Y., Li, W., Wang, X., Benzinger, T. L. S., Lu, J., & Zhou, Y. (2021) · Brain · doi:10.1093/brain/awab160 · Cited by 61
Associations of Sex, Race, and Apolipoprotein E Alleles With Multiple Domains of Cognition Among Older Adults
Walters, S., Contreras, A. G., Eissman, J. M., Mukherjee, S., Lee, M. L., Choi, S., Scollard, P., Trittschuh, E. H., Mez, J., Bush, W. S., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.2169 · Cited by 65
APOE and BDNF Val66Met polymorphisms combine to influence episodic memory function in older adults
Ward, D. D., Summers, M. J., Saunders, N. L., Janssen, P., Stuart, K. E., & Vickers, J. C. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.06.022 · Cited by 64
Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases
Minta, K., Brinkmalm, G., Janelidze, S., Sjödin, S., Portelius, E., Stomrud, E., Zetterberg, H., Blennow, K., Hansson, O., & Andréasson, U. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00585-7 · Cited by 57
ApoE e2 and aging-related outcomes in 379,000 UK Biobank participants
Kuo, C.-L., Pilling, L. C., Atkins, J. L., Kuchel, G. A., & Melzer, D. (2020) · Aging · doi:10.18632/aging.103405 · Cited by 55
Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
Salvadó, G., Grothe, M. J., Groot, C., Moscoso, A., Schöll, M., Gispert, J. D., Ossenkoppele, R., & Initiative, A. D. N. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05192-8 · Cited by 57
Clinical phenotype, atrophy, and small vessel disease in APOE ε2 carriers with Alzheimer disease
Groot, C., Sudre, C. H., Barkhof, F., Teunissen, C. E., van Berckel, B. N. M., Seo, S. W., Sebastien Ourselin, A., Scheltens, P., Cardoso, M. J., van der Flier, W. M., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006503 · Cited by 54
Molecular Insight into the Therapeutic Promise of TargetingAPOE4for Alzheimer’s Disease
Mamun, A. A., Uddin, M. S., Bashar, M. F. B., Zaman, S., Begum, Y., Bulbul, I. J., Islam, M. S., Sarwar, M. S., Mathew, B., Amran, M. S., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5086250 · Cited by 54
Associations between APOE genotype and cerebral small-vessel disease: a longitudinal study
Luo, X., Initiative, A. D. N., Jiaerken, Y., Yu, X., Huang, P., Qiu, T., Jia, Y., Li, K., Xu, X., Shen, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17724 · Cited by 53
The Proportion of APOE4 Carriers Among Non-Demented Individuals: A Pooled Analysis of 389,000 Community-Dwellers
Wang, Y.-Y., Ge, Y.-J., Tan, C.-C., Cao, X.-P., Tan, L., & Xu, W. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-201606 · Cited by 49
Effect of age and the APOE gene on metabolite concentrations in the posterior cingulate cortex
Suri, S., Emir, U. E., Stagg, C. J., Near, J., Ralf Mekle, A., Schubert, F., Zsoldos, E., Mahmood, A., Singh‐Manoux, A., Mika Kivimaki, B., et al. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.03.031 · Cited by 49
Self-citation
Working Memory in Alzheimer’s Disease and Parkinson’s Disease
Zokaei, N., & Husain, M. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_103 · Cited by 52
Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual Brain
Stefanovski, L., Meier, J. M., Pai, R. K., Triebkorn, P., Lett, T. A. P., Martin, L., Bülau, K., Hofmann‐Apitius, M., Solodkin, A., McIntosh, A. R., et al. (2021) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2021.630172 · Cited by 47
β-amyloid: The known unknowns
Ayton, S., & Bush, A. I. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101212 · Cited by 45
Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load
Grothe, M. J., Villeneuve, S., Dyrba, M., Bartrés‐Faz, D., Wirth, M., Initiative, A. D. N., Initiative, A. D. N., Weiner, M. W., Aisen, P., Weiner, M. W., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003585 · Cited by 47
Apolipoprotein E genotypes among diverse middle-aged and older Latinos: Study of Latinos-Investigation of Neurocognitive Aging results (HCHS/SOL)
González, H. M., Tarraf, W., Jian, X., Vásquez, P. M., Kaplan, R. C., Thyagarajan, B., Daviglus, M. L., Lamar, M., Gallo, L. C., Zeng, D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35573-3 · Cited by 44
Successful cognitive aging is associated with thicker anterior cingulate cortex and lower tau deposition compared to typical aging
Pezzoli, S., Giorgio, J., Martersteck, A., Dobyns, L., Harrison, T. M., & Jagust, W. J. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13438 · Cited by 42
Sex differences in dementia: on the potentially mediating effects of educational attainment and experiences of psychological distress
Hasselgren, C., Ekbrand, H., Halleröd, B., Fässberg, M. M., Zettergren, A., Johansson, L. H., Skoog, I. G., & Dellve, L. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02820-9 · Cited by 46
A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer’s Disease
Khan, W., Initiative, A. D. N., Giampietro, V., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Büchel, C., Conrod, P., Flor, H., Frouin, V., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161097 · Cited by 41
Apolipoprotein E epsilon 4 ( APOE ‐ε4) genotype is associated with decreased 6‐month verbal memory performance after mild traumatic brain injury
Yue, J. K., Robinson, C. K., Burke, J. F., Winkler, E. A., Deng, H., Cnossen, M. C., Lingsma, H. F., Ferguson, A. R., McAllister, T. W., Rosand, J. M., et al. (2017) · Brain and Behavior · doi:10.1002/brb3.791 · Cited by 41
Sorting Out the Role of the Sortilin-Related Receptor 1 in Alzheimer’s Disease
Barthelson, K., Newman, M., & Lardelli, M. T. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200177 · Cited by 43
APOE ɛ4 Gene Dose and Sex Effects on Alzheimer’s Disease MRI Biomarkers in Older Adults with Mild Cognitive Impairment
Hobel, Z., ageing, F. T. A. D. N. I. A. T. A. I. B. A. L. F. S. O., Isenberg, A. L., Raghupathy, D., Mack, W., & Pa, J. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180859 · Cited by 40
Apolipoprotein E Genotype e2: Neuroprotection and Its Limits
Kim, H., Devanand, D. P., Carlson, S., & Goldberg, T. E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.919712 · Cited by 41
Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults
Pereira, J. B., Harrison, T. M., Joie, R. L., Baker, S. L., & Jagust, W. J. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04669-x · Cited by 40
Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
Hirschfeld, L. R., Risacher, S. L., Nho, K. T., & Saykin, A. J. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00321-1 · Cited by 41
RETRACTION OF: A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition
Sawmiller, D. R., Habib, A., Hou, H., Mori, T., Fan, A., Tian, J., Jin, Z., Giunta, B. N., Sanberg, P. R., Mattson, M. P., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.026 · Cited by 38
Retracted
Race-Related Association between APOE Genotype and Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Qin, W., Li, W., Wang, Q., Gong, M., Li, T., Shi, Y., Song, Y., Li, Y., Li, F., & Jia, J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210549 · Cited by 37
APOE ε4 Modifies Effect of Residential Greenness on Cognitive Function among Older Adults: A Longitudinal Analysis in China
Zhu, A., Yan, L. L., Shu, C., Zeng, Y., & Ji, J. S. (2020) · Scientific Reports · doi:10.1038/s41598-019-57082-7 · Cited by 36
APOE2 mitigates disease-related phenotypes in an isogenic hiPSC-based model of Alzheimer’s disease
Brookhouser, N., Raman, S., Frisch, C., Srinivasan, G., & Brafman, D. A. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01076-3 · Cited by 33
The ApoE ε4 Isoform: Can the Risk of Diseases be Reduced by Environmental Factors?
Bos, M. M., Noordam, R., Blauw, G. J., Slagboom, P. E., Rensen, P. C. N., & van Heemst, D. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly226 · Cited by 32
Protective role of the apolipoprotein E2 allele in age-related disease traits and survival: evidence from the Long Life Family Study
Kulminski, A. M., Raghavachari, N., Arbeev, K. G., Culminskaya, I. V., Arbeeva, L. S., Wu, D., Ukraintseva, S. V., Christensen, K., & Yashin, A. I. (2016) · Biogerontology · doi:10.1007/s10522-016-9659-3 · Cited by 31
Impact of Apolipoprotein E gene polymorphism during normal and pathological conditions of the brain across the lifespan
Iacono, D., & Feltis, G. C. (2019) · Aging · doi:10.18632/aging.101757 · Cited by 36
Intrinsic functional connectivity alterations in cognitively intact elderly APOE ε4 carriers measured by eigenvector centrality mapping are related to cognition and CSF biomarkers: a preliminary study
ADNI, Luo, X., Qiu, T., Jia, Y., Huang, P., Xu, X., Yu, X., Shen, Z., Jiaerken, Y., Guan, X., et al. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9600-z · Cited by 30
APOE modifies the interaction of entorhinal cerebral blood flow and cortical thickness on memory function in cognitively normal older adults
Hays, C. C., Zlatar, Z. Z., Meloy, M. J., Bondi, M. W., Gilbert, P. E., Liu, T. T., Helm, J. L., & Wierenga, C. E. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.116162 · Cited by 32
Genetic and regulatory architecture of Alzheimer's disease in the APOE region
Kulminski, A. M., Shu, L., Loika, Y., He, L., Nazarian, A., Arbeev, K. G., Ukraintseva, S. V., Yashin, A. I., & Culminskaya, I. V. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12008 · Cited by 29
APOE Polymorphism Affects Brain Default Mode Network in Healthy Young Adults
Su, Y. Y., Liang, X., Schoepf, U. J., Varga‐Szemes, Á., West, H. C., Qi, R., Kong, X., Chen, H., Lu, G., & Zhang, L. J. (2015) · Medicine · doi:10.1097/md.0000000000001734 · Cited by 30
Effect of apolipoprotein genotype and educational attainment on cognitive function in autosomal dominant Alzheimer’s disease
Langella, S., Barksdale, N. G., Vasquez, D., Aguillon, D., Chen, Y., Su, Y., Acosta-Baena, N., Acosta-Uribe, J., Baena, A. Y., Garcia-Ospina, G., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40775-z · Cited by 30
Sex differences in risk of Alzheimer's disease in adults with Down syndrome
Lai, F., Mhatre, P. G., Yang, Y., Wang, M., Schupf, N., & Rosas, H. D. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12084 · Cited by 29
Affect of APOE on information processing speed in non-demented elderly population: a preliminary structural MRI study
Initiative, A. D. N., Luo, X., Jiaerken, Y., Yu, X., Huang, P., Qiu, T., Jia, Y., Sun, J., Zhou, J., & Zhang, M. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9571-0 · Cited by 29
Dissociable effects of the apolipoprotein-E (APOE) gene on short- and long-term memories
Zokaei, N., Čepukaitytė, G., Alexander Board, Mackay, C. E., Husain, M., & Nobre, A. C. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.09.017 · Cited by 26
Self-citation
APOE region molecular signatures of Alzheimer's disease across races/ethnicities
Kulminski, A. M., Shu, L., Loika, Y., Nazarian, A., Arbeev, K. G., Ukraintseva, S. V., Yashin, A. I., & Culminskaya, I. V. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.11.007 · Cited by 28
Alzheimer’s disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals
Pettigrew, C. A., Nazarovs, J., Soldan, A., Singh, V., Wang, J., Hohman, T. J., Dumitrescu, L. C., Libby, J. B., Kunkle, B. W., Gross, A. L., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01206-9 · Cited by 31
Genetic Alzheimer’s Disease Risk Affects the Neural Mechanisms of Pattern Separation in Hippocampal Subfields
Lee, H. L., Stirnberg, R., Wu, S., Wang, X., Stöcker, T., Jung, S., Montag, C., & Axmacher, N. (2020) · Current Biology · doi:10.1016/j.cub.2020.08.042 · Cited by 27
APOE E2/E2 Is Associated with Slower Rate of Cognitive Decline with Age
Sweigart, B., Andersen, S. L., Gurinovich, A., Cosentino, S., Schupf, N., Perls, T. T., & Sebastiani, P. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201205 · Cited by 25
The Roles of Apolipoprotein E, Lipids, and Glucose in the Pathogenesis of Alzheimer’s Disease
Shinohara, M., & Sato, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_5 · Cited by 28
Protective Variants in Alzheimer’s Disease
Andrews, S. J., Fulton‐Howard, B., & Goate, A. (2019) · Current Genetic Medicine Reports · doi:10.1007/s40142-019-0156-2 · Cited by 25
Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?
Lozupone, M., Imbimbo, B. P., Balducci, C., Vecchio, F. L., Bisceglia, P., Latino, R. R., Leone, M. A., Dibello, V., Solfrizzi, V., Greco, A., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12728 · Cited by 28
APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease
Ayyubova, G. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230303114425 · Cited by 23
Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease
Zota, I., Chanoumidou, K., Gravanis, A., & Charalampopoulos, I. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1422130 · Cited by 25
Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow‐up study
Scarabino, D., Broggio, E., Gambina, G., Maida, C., Gaudio, M., & Corbo, R. M. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32495 · Cited by 24
Associations of Apolipoprotein E ε4 Genotype and Ball Heading With Verbal Memory in Amateur Soccer Players
Hunter, L. E., Freudenberg‐Hua, Y., Davies, P., Kim, M., Lipton, R. B., Stewart, W. F., Srinivasan, P., Hu, S., & Lipton, M. L. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4828 · Cited by 26
Associations Between APOE Variants, Tau and α-Synuclein
Rodriguez‐Vieitez, E., & Nielsen, H. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_15 · Cited by 24
APOE – a genetic marker of comorbidity in subjects with morbid obesity
Farup, P. G., Rootwelt, H., & Hestad, K. A. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-01082-2 · Cited by 25
Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors
Zhou, X., Zhang, X., Zhong, T., Zhou, M., Gao, L., & Chen, L. (2023) · Journal of Advanced Nursing · doi:10.1111/jan.15842 · Cited by 24
Effect of apolipoprotein E polymorphism on cognition and brain in the Cambridge Centre for Ageing and Neuroscience cohort
Henson, R. N., Suri, S., Knights, E., Rowe, J. B., Kievit, R., Lyall, D. M., Chan, D., Eising, E., & Fisher, S. E. (2020) · Brain and Neuroscience Advances · doi:10.1177/2398212820961704 · Cited by 26
Self-citation
The protective gene dose effect of the APOEε2 allele on gray matter volume in cognitively unimpaired individuals
Salvadó, G., Ferreira, D., Operto, G., Cumplido‐Mayoral, I., Arenaza‐Urquijo, E. M., Cacciaglia, R., Falcón, C., Vilor‐Tejedor, N., Minguillón, C., Groot, C., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12487 · Cited by 21
Sex differences in associations between APOE ε2 and longitudinal cognitive decline
Alexander, M. W., Xiong, L. Y., Wong, Y. Y., Buckley, R. F., Swardfager, W., Masellis, M., Lim, A. S. P., Nichols, E., Joie, R. L., Casaletto, K. B., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13036 · Cited by 25
APOE signaling in neurodegenerative diseases: an integrative approach targeting APOE coding and noncoding variants for disease intervention
Zhou, X., Fu, A. K. Y., & Ip, N. Y. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.02.001 · Cited by 23
How Research on Human Progeroid and Antigeroid Syndromes Can Contribute to the Longevity Dividend InitiativePreprint
Hisama, F. M., Oshima, J., & Martin, G. M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025882 · Cited by 21
Does apolipoprotein E genotype influence cognition in middle-aged individuals?
Salvato, G. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000262 · Cited by 22
APOE ε4 associated with preserved executive function performance and maintenance of temporal and cingulate brain volumes in younger adults
Taylor, W. D., Boyd, B. D., Turner, R. M., McQuoid, D. R., Ashley‐Koch, A. E., MacFall, J. R., Saleh, A., & Potter, G. G. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9522-9 · Cited by 23
APOE ε4 Genotype and Cognitive Reserve Effects on the Cognitive Functioning of Healthy Elders
López, M. E., Turrero, A., Delgado‐Losada, M. L., Rodríguez‐Rojo, I. C., Arrazola, J., Barabash, A., Maestú, F., & Fernández, A. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000481852 · Cited by 21
Young people's moral attitudes and motivations towards direct-to-consumer genetic testing for inherited risk of Alzheimer disease
Pavarini, G., Hamdi, L., Lorimer, J., & Singh, I. (2021) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2021.104180 · Cited by 20
Altered effective connectivity anchored in the posterior cingulate cortex and the medial prefrontal cortex in cognitively intact elderly APOE ε4 carriers: a preliminary study
Initiative, A. D. N., Luo, X., Li, K., Jia, Y., Zeng, Q., Jiaerken, Y., Qiu, T., Huang, P., Xu, X., Shen, Z., et al. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-9857-5 · Cited by 20
The Potential of Pathological Protein Fragmentation in Blood-Based Biomarker Development for Dementia – With Emphasis on Alzheimer’s Disease
Inekci, D., Jonesco, D. S., Kennard, S., Karsdal, M. A., & Henriksen, K. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00090 · Cited by 19
Differential Effect of APOE Alleles on Brain Glucose Metabolism in Targeted Replacement Mice: An [18F]FDG-μPET Study
Venzi, M., Tóth, M., Häggkvist, J., Bogstedt, A., Rachalski, A., Mattsson, A., Frumento, P., & Farde, L. (2017) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-170006 · Cited by 18
Investigating the synergistic effects of hormone replacement therapy, apolipoprotein E and age on brain health in the UK Biobank
Ambikairajah, A., Khondoker, M. R., Morris, E., de Lange, A. G., Saleh, R. N. M., Minihane, A. M., & Hornberger, M. (2024) · Human Brain Mapping · doi:10.1002/hbm.26612 · Cited by 17
Humanin variant P3S is associated with longevity in APOE4 carriers and resists APOE4‐induced brain pathology
Miller, B., Kim, S., Cao, K., Mehta, H. H., Thumaty, N., Kumagai, H., Iida, T., McGill, C. J., Pike, C. J., Nurmakova, K., et al. (2024) · Aging Cell · doi:10.1111/acel.14153 · Cited by 19
Possible positive effect of the APOE ε2 allele on cognition in early to mid-adult life
Sinclair, L. I., Pleydell-Pearce, C. W., & Day, I. N. M. (2017) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2017.10.008 · Cited by 20
Interaction of APOE, cerebral blood flow, and cortical thickness in the entorhinal cortex predicts memory decline
Hays, C. C., Zlatar, Z. Z., Meloy, M. J., Bondi, M. W., Gilbert, P. E., Liu, T., Helm, J. L., & Wierenga, C. E. (2020) · Brain Imaging and Behavior · doi:10.1007/s11682-019-00245-x · Cited by 19
Default mode network connectivity and cognition in the aging brain: the effects of age, sex, and APOE genotype.
Shafer, A. T., Beason-Held, L., An, Y., Williams, O. A., Huo, Y., Landman, B. A., Caffo, B. S., & Resnick, S. M. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.03.013 · Cited by 16
Risk-reducing Apolipoprotein E and Clusterin genotypes protect against the consequences of poor vascular health on executive function performance and change in nondemented older adults
McFall, G. P., Sapkota, S., McDermott, K. L., & Dixon, R. A. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.032 · Cited by 17
Human Apolipoprotein E Genotype Differentially Affects Olfactory Behavior and Sensory Physiology in Mice
East, B. S., Fleming, G., Peng, K., Olofsson, J., Levy, E., Mathews, P. M., & Wilson, D. A. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.04.009 · Cited by 20
Exploring the effect of the apolipoprotein E (APOE) gene on executive function, working memory, and processing speed during the early recovery period following traumatic brain injury
Padgett, C. R., Summers, M. J., Vickers, J. C., McCormack, G. H., & Skilbeck, C. E. (2016) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2015.1137557 · Cited by 17
Arabidopsis thaliana extracts optimized for polyphenols production as potential therapeutics for the APOE-modulated neuroinflammation characteristic of Alzheimer’s disease in vitro
Ghura, S., Tai, L. M., Zhao, M., Collins, N., Che, C., Warpeha, K. M., & LaDu, M. J. (2016) · Scientific Reports · doi:10.1038/srep29364 · Cited by 17
The Effect of Gender and APOE ɛ4 Status on Brain Amyloid-β Deposition in Different Age Groups of Mild Cognitively Impaired Individuals: A PET-CT Study
Wang, J., Wang, M., Ren, S., Huang, L., He, K., Li, J., Hua, F., Guan, Y., Guo, Q., Huang, Q., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221166 · Cited by 15
Decreased Inter-Hemispheric Functional Connectivity in Cognitively Intact Elderly APOE ɛ 4 Carriers: A Preliminary Study
Luo, X., Qiu, T., Xu, X., Huang, P., Gu, Q., Shen, Z., Yu, X., Jia, Y., Guan, X., Song, R., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150989 · Cited by 16

Authors: Suri, S., Heise, V., Trachtenberg, A. J., & Mackay, C. E.
Affiliations: John Radcliffe Hospital (GB)
Corresponding author: Mackay, Clare E.
ORCID: Suri, Sana
Heise, Verena
Trachtenberg, Aaron J.
Mackay, Clare E.
Venue: Neuroscience & Biobehavioral Reviews
Publisher: Elsevier BV
Published: 2013-12
Volume: 37
Issue: 10
Pages: 2878-2886
ISSN: 0149-7634 (ISSN-L)
DOI: 10.1016/j.neubiorev.2013.10.010
OpenAlex: W2067079625
Cited by: 183
References: 126
Citations by year: 2026: 6 · 2025: 9 · 2024: 14 · 2023: 15 · 2022: 15 · 2021: 24 · 2020: 26 · 2019: 14 · 2018: 11 · 2017: 14 · 2016: 18 · 2015: 14 · 2014: 3
FWCI: 1.29
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neuroscience & Biobehavioral Reviews (publishedVersion)
PubMed (publishedVersion)
Funders: University of Oxford Clarendon scholarship
Alzheimer's Research UK studentship
Rhodes scholarship
National Institute for Health Research (NIHR), UK
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: APOE ε2 allele, APOE ε4, apolipoprotein E, Alzheimer's disease, neuroprotection, cognitive health, longevity, neurodegeneration, brain structure and function, protective genetic factor
MeSH terms: Alleles, Cognition Disorders, Genotype, Humans, Longevity, Risk Factors, Neurodegenerative Diseases, Apolipoprotein E2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The forgotten APOE allele: A review of the evidence and suggested mechanisms for the protective effect of APOE ɛ2

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks